Portable stress and mental illness objective index assessment test strip and method

Through the evaluation of the use of test strips through objective indicators of portable stress and mental illness, the problem of insufficient sensitivity of cortisol and DHEA/DHEAS hormones in the prior art is solved, and rapid, accurate and low-cost detection is achieved, suitable for grassroots and social health scenarios Under stress and mental illness screening.

CN112858699BActive Publication Date: 2024-11-22SHENZHEN LIANGDIAN TECH CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202110217787.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-02-26
Publication Date
2024-11-22
Estimated Expiration
2041-02-26

AI Technical Summary

Technical Problem

In the prior art, when detecting stress-regulating hormones such as cortisol and DHEA/DHEAS, there are problems such as insufficient detection sensitivity, complex operation, expensive equipment, and unsuitable for portable mobile detection.

Method used

The test strips were evaluated using objective indicators of portable pressure and mental illness, including glass cellulose membrane, nitrocellulose membrane and PVC plate, and sprayed with probes coupled to specific antibodies of different specifications but the same wavelength, combined with independent quality control Lines and detection lines, evaluating hormone concentration through fluorescence ratios, achieving rapid and accurate detection.

Benefits of technology

It has achieved multi-indicator testing within 6 minutes, with good stability in chromatography time and low cost, suitable for accurate testing at the grassroots and social health scenarios, and can meet the quantitative detection of daily rhythm and stress regulation-related hormones, simplifying the operation process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN112858699B_ABST
    Figure CN112858699B_ABST
Patent Text Reader

Abstract

The present invention discloses a portable stress and mental illness objective index assessment test strip and method, including a glass cellulose membrane, a nitrocellulose membrane, a blotting paper, a PVC board and a closed box cover; the glass cellulose membrane is provided with a probe spraying area, the probe spraying area is sprayed with quantum dot coupled probes and independent antibody probes of different specifications, and the nitrocellulose membrane is provided with a quality control line and a detection line; the sample is dripped in the through hole of the closed box cover, and the data of the quality control line and the detection line are read in the transparent position of the closed box cover by a detection and analysis device, and the detection result is evaluated according to the fluorescence intensity and ratio of the quantum dots. The present invention can complete the detection of multiple indicators within 6 minutes at the shortest, and the detection concentration change does not exceed 10% within 10 minutes after the chromatography is completed, and does not exceed 15% within one hour, and has good time stability, and the quantitative detection CV of each indicator key interval is within 10%, and the inspection operation is simple, which can meet the detection accuracy requirements of the grassroots and the relatively busy community health.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of in vitro diagnosis, and in particular to a portable stress and mental illness objective indicator assessment test strip and a use method thereof. Background Art

[0002] Cortisol, also known as hydrocortisone, is a type of glucocorticoid extracted from the adrenal cortex that regulates carbohydrate metabolism. It participates in mediating people's daily rhythms and maintains human endocrine and circadian homeostasis through the negative feedback mechanism of the HPA axis in stress response and pressure regulation. DHEA / DHEAS is a small molecule precursor of cortisol. Its blood concentration is correlated with cortisol and can be used in combination to diagnose endocrine disorders related to stress and long-term stress. A large number of domestic and foreign studies have shown that it is closely related to stress-related mental illnesses such as anxiety and depression. Compared with traditional self-assessment, peer-assessment scales and doctor's consultations, blood or urine tests of biomarkers and marker combinations can greatly reduce the impact of subjective consciousness on test results, and overcome common problems in the diagnosis and census of mental stress and diseases, such as the shortage of professional doctors and the shortage of medical resources.

[0003] At present, the detection of stress-regulating hormones such as cortisol and DHEA / DHEAS is based on enzyme-linked immunosorbent assay (ELISA) test kits (such as Chinese patents CN102520165B and CN111351945A and some marketed products), which are relatively complicated to operate and the reaction time is usually 6-24 hours. This type of test kit has good detection sensitivity, but there are many manual operation components, the experimental steps are relatively complicated, the reading equipment is relatively expensive, it is difficult to ensure the detection precision and timeliness, and there are also difficulties in the transportation, storage and application promotion of the test kit.

[0004] Among the existing immunochromatographic techniques, the visual qualitative and semi-quantitative methods based on colloidal gold are relatively mature. By observing the red detection band (T line) with the naked eye, the corresponding concentration of the tested protein can be roughly evaluated. Compared with the ELISA method, it has obvious advantages in the detection of large molecular proteins such as pregnancy test and ovulation. However, for the small hormone molecules involved in this project, the colloidal gold immunochromatographic technology cannot achieve the detection sensitivity required for clinical use, let alone accurate quantification and stable test results.

[0005] Quantum dots are a type of nano-scale semiconductor luminescent material, usually composed of II-VI or III-V group elements in its core structure, with the characteristics of high luminescence intensity, good thermal stability, and strong resistance to photobleaching. The particle size, uniformity, core-shell structure composition and surface modification of quantum dot materials have a significant impact on the luminescence wavelength and the performance of immunochromatographic reagents.

[0006] Some studies have used quantum dots of different particle sizes (luminescence wavelengths) as labeling materials for different detection indicators of multiplex testing. Although they have good effects in overcoming interference and improving detection accuracy, quantum dots of different luminescence wavelengths are suitable for different optical components in immunofluorescence analyzers. In order to achieve ideal detection sensitivity and obvious distinction, the equipment hardware optical module and software parameters need to be coordinated, which leads to a significant increase in equipment size and cost, making it unsuitable for portable mobile testing.

[0007] Therefore, considering the defects of the above-mentioned prior art and specific usage requirements, the present invention proposes targeted improvements. Summary of the invention

[0008] The technical problem to be solved by the present invention is to provide a portable stress and mental illness objective indicator assessment test strip and a method of use to solve the technical and application problems of the above-mentioned existing methodology.

[0009] The technical scheme of the present invention is as follows: a portable stress and mental illness objective index assessment test strip, comprising a glass cellulose membrane, a nitrocellulose membrane, absorbent paper, a PVC board and a closed box cover;

[0010] The PVC board is arranged in the closed box cover, the glass cellulose membrane, the nitrocellulose membrane and the absorbent paper are arranged on the PVC board, and the two ends of the nitrocellulose membrane are connected to the glass cellulose membrane and the absorbent paper respectively;

[0011] A probe spraying area is arranged at one end of the glass cellulose membrane close to the nitrocellulose membrane, and the probe spraying area is sprayed with coupled probes and independent antibody probes, wherein the coupled probes are probes coupled with quantum dots of different specifications but the same wavelength and specific antibodies;

[0012] The nitrocellulose membrane is provided with a quality control line and at least one detection line in parallel, the quality control line is far away from the glass cellulose membrane, and the detection line is close to the glass cellulose membrane;

[0013] The detection line is sprayed with antigens combined with detection-specific probes, and the quality control line is sprayed with independent antigens combined with quality control independent antibody probes.

[0014] Preferably, the quantum dots are CdSe / ZnS core-shell quantum dots of various specifications with different polymerization degrees, and the luminescent wavelength is still generated by the raw material core-shell quantum dots themselves and is hardly affected by the polymerization degree.

[0015] Preferably, the specific antibody is a single Cortisol-specific antibody, or a single DHEA-specific antibody, or a single DHEAS-specific antibody, or one of Cortisol and DHEA / DHEAS, a total of specific antibodies for both indicators.

[0016] Preferably, the specific antibody comprises rabbit IgG monoclonal antibody or mouse IgG monoclonal antibody against the target small molecule.

[0017] Preferably, the detection line comprises T1 and T2, and the antigens corresponding to the specific antibodies are sprayed on T1 and T2 respectively.

[0018] Preferably, the independent antibody in the independent antibody quality control probe is a DNP-BSA antibody, the quality control line is C, and the independent antigen is a DNP-BSA antigen.

[0019] Preferably, the closed box cover comprises an upper cover and a lower cover, a PVC plate is placed inside the lower cover, and a through hole is provided in the upper cover, wherein the through hole is located above the end of the glass cellulose membrane away from the nitrocellulose membrane.

[0020] Preferably, the upper cover is provided with a transparent observation window, and the transparent observation window is located above the quality control line and the detection line.

[0021] A portable stress and mental illness objective indicator assessment method, including the portable stress and mental illness objective indicator assessment test strip;

[0022] The following steps are also included:

[0023] S1. Spray the specific detection probe and the independent quality control antibody probe on the probe spraying area of ​​the glass cellulose membrane close to the nitrocellulose membrane;

[0024] The detection specific antibody probe is a probe formed by coupling quantum dots of different specifications but the same wavelength with specific antibodies. The specific antibody is a single cortisol-specific antibody, or a single DHEA-specific antibody, or a single DHEAS-specific antibody, or one of cortisol and DHEA / DHEAS, a total of specific antibodies for two indicators respectively;

[0025] The antibody in the independent quality control antibody probe is DNP-BSA antibody;

[0026] S2, set two detection lines and one quality control line on the nitrocellulose membrane, namely T1, T2 and C, T1 is located between the nitrocellulose membrane and T2, and T2 is located between T1 and C;

[0027] S3, spraying antigens corresponding to the detection-specific antibody probe on T1 and T2; spraying DNP-BSA antigens corresponding to the DNP-BSA antibody on C;

[0028] S4, mixing 5 to 20 ul of the blood sample or urine sample with the diluent to form a 60 to 80 ul mixed solution, and dripping the mixed solution onto the glass cellulose membrane at the through-hole position of the upper cover;

[0029] S5, waiting time for response is 6 to 10 minutes;

[0030] S6, using the detection and analysis device to read the fluorescence data of the quality control line and the detection line from the transparent observation window, and according to the ratio of the fluorescence data of the detection line to the fluorescence data of the quality control line

[0031] Test results assessing stress and mental illness.

[0032] By adopting the above-mentioned technical solutions, the present invention can complete the detection of multiple indicators within 6 minutes at the shortest. The detection concentration change does not exceed 10% within 10 minutes after the chromatography is completed, and does not exceed 15% within one hour, which has good time stability. The time accuracy requirement for reading the results is low, it is easy to use, simple to operate, and low in cost, and can meet the detection accuracy requirements of grassroots and community health under busy conditions.

[0033] At the same time, the present invention combines the characteristics of quantum dots with high luminescence intensity, long fluorescence lifetime and small particle size. Compared with conventional colloidal gold detection, it can meet the requirements of low concentration, especially the competitive quantitative detection of cortisol or DHEA / DHEAS hormone small molecules related to daily rhythm and stress regulation. Compared with the ELISA detection method, it can meet the requirements of handheld devices to read the results, and even use the UV light source of a banknote detector pen to observe and compare the brightness of the fluorescent strips for preliminary analysis, thereby achieving the purpose of screening and evaluating stress and mental illness in different scenarios. BRIEF DESCRIPTION OF THE DRAWINGS

[0034] Figure 1 It is a structural schematic diagram of the present invention;

[0035] Figure 2 It is a schematic diagram of the stability of multiple groups of test data of the present invention;

[0036] Figure 3 It is a schematic diagram of the detection result of a detection line of the present invention;

[0037] Figure 4 It is a schematic diagram of the detection results of two detection lines of the present invention.

[0038] Description of reference numerals:

[0039] 1. Glass cellulose membrane;

[0040] 2. Spray probe area;

[0041] 3. Quantum dots;

[0042] 4. Cortisol (DHEA / DHEAS) antibodies;

[0043] 5. Blood sample or urine sample;

[0044] 6. Nitrocellulose membrane;

[0045] 7. Cortisol (DHEA / DHEAS) antigen;

[0046] 8. Test line (T1);

[0047] 9. Test line (T2);

[0048] 10. Quality control line (C);

[0049] 11. DNP-BSA antigen;

[0050] 12. PVC board;

[0051] 13. Absorbent paper;

[0052] 14. Lower cover;

[0053] 15. Upper cover;

[0054] 16. Transparent observation window;

[0055] 17. DNP-BSA antibody. DETAILED DESCRIPTION

[0056] The present invention is described in detail below in conjunction with the accompanying drawings and specific embodiments.

[0057] Embodiment 1

[0058] like Figure 1 This embodiment provides a portable stress and mental illness objective index assessment test strip, including a glass cellulose membrane 1, a nitrocellulose membrane 6, absorbent paper 13, a PVC board 12 and a closed box cover.

[0059] The PVC plate 12 is arranged in the closed box cover, and the closed box cover includes an upper cover 15 and a lower cover 14, and the PVC plate 12 is placed at the bottom of the lower cover 14. The upper cover 15 is provided with a through hole for dripping a blood sample or a urine sample. The upper cover 15 is provided with a transparent observation window 16, which is located above the quality control line 10 and the detection line (8 / 9) and is used for the detection device to read the signal data of the quality control line 10 and the detection line (8 / 9).

[0060] The glass cellulose membrane 1 , the nitrocellulose membrane 6 and the absorbent paper 13 are arranged on the PVC plate 12 , and the two ends of the nitrocellulose membrane 6 are connected to the glass cellulose membrane 1 and the absorbent paper 13 respectively.

[0061] The end of the glass cellulose membrane 1 close to the nitrocellulose membrane 6 is provided with a spray probe area 2, and the other end of the glass cellulose membrane 1 is below the through hole, which is set as the sample end. The glass cellulose membrane has been specially treated, and the height from the sample end to the spray probe area 2 gradually increases, which can effectively block the blood cells of the whole blood sample on the glass cellulose membrane 1 after the sample is added, and no signal or reaction is generated in the detection area to interfere. That is, the glass cellulose membrane 1 has been sealed, and the right end is slightly higher than the left end, which can ensure the stability and reliability of the test.

[0062] The probe spraying area 2 is sprayed with detection-specific antibody probes and independent quality control antibody probes. The detection probes are probes formed by coupling quantum dots 3 and specific antibodies 4 of different specifications but the same wavelength.

[0063] The nitrocellulose membrane 6 is provided with a quality control line and at least one detection line in parallel, wherein the quality control line is far away from the glass cellulose membrane 1 , and the detection line is close to the glass cellulose membrane 1 .

[0064] The test line is sprayed with antigens combined with test-specific antibody probes, and the quality control line is sprayed with independent antigens combined with independent quality control antibody probes.

[0065] Quantum dot 3 is a variety of CdSe / ZnS core-shell quantum dots with different polymerization degrees. The luminescence wavelength is still generated by the raw material core-shell quantum dots themselves and is almost unaffected by the polymerization degree.

[0066] When a T line is used as the detection line, quantum dots 3 with the same specification and wavelength are selected.

[0067] When two detection lines are used, namely T1 (8) and T2 (9), quantum dots 3 of different specifications but the same wavelength are selected. Small-sized quantum dots are monodisperse quantum dots, and large-sized quantum dots are aggregated quantum dots. The chromatography speed of the probe labeled with monodisperse quantum dots is slightly faster than that of the probe labeled with aggregated quantum dots. The probe labeled with monodisperse quantum dots corresponds to the detection line T2 at a farther position, and the probe labeled with aggregated quantum dots corresponds to the detection line T1 at a closer position. Different detection items can complete the reaction in the same short time, reducing mutual interference, while ensuring that all fluorescence results can be read with the same optical system, reducing errors caused by hardware differences.

[0068] Among them, specific antibody 4 is a single specific antibody for cortisol, a single specific antibody for DHEA, a single specific antibody for DHEAS, or a specific antibody for either cortisol or DHEA / DHEAS, for a total of two indicators (two-combination test). That is, if it is a two-combination test, specific antibody 4 must contain cortisol, and cortisol and any one of DHEA / DHEAS must be used in combination.

[0069] The specific antibody 4 includes rabbit IgG monoclonal antibody or mouse IgG monoclonal antibody against the target small molecule.

[0070] T1 (8) and T2 (9) are sprayed with antigens corresponding to the specific antibodies. When the specific antibody 4 is a single cortisol-specific antibody, only one T line is needed for the cortisol-specific antigen 7. When the specific antibody is coupled to either cortisol or DHEA / DHEAS, T1 (8) and T2 (9) are at least one of the cortisol antigen and the DHEA / DHEAS antigen, respectively.

[0071] The antibody in the independent quality control antibody probe is DNP-BSA antibody 17, the quality control line is C(10), and the independent antigen is DNP-BSA antigen 11.

[0072] Embodiment 2

[0073] According to the structure of the first embodiment, this embodiment is a portable stress and mental illness objective indicator evaluation method, including the portable stress and mental illness objective indicator evaluation test strip of the first embodiment. The test strips detect items including cortisol and DHEA / DHEAS hormones, and the types of diseases evaluated include chronic stress, stress, and mental illness and endocrine disorders caused by long-term stress and stimulation.

[0074] The specific steps include:

[0075] S1. Spray the coupled probe and the independent antibody probe on the probe spraying area 2 on the side of the glass cellulose membrane 1 close to the nitrocellulose membrane 6.

[0076] The coupled probes are probes formed by coupling quantum dots of different specifications but the same wavelength to specific antibodies, and the specific antibodies are single cortisol-specific antibodies, or single DHEA-specific antibodies, or single DHEAS-specific antibodies, or specific antibodies coupled to cortisol and one of DHEA / DHEAS (double test).

[0077] The independent antibody in the independent antibody probe is DNP-BSA antibody.

[0078] S2. Two detection lines and one quality control line are set on the nitrocellulose membrane 6, namely T1, T2 and C. T1 is located between the nitrocellulose membrane 1 and T2, and T2 is located between T1 and C.

[0079] S3, spray the antigen corresponding to the coupled probe on T1 and T2, and spray the DNP-BSA antigen corresponding to the DNP-BSA antibody on C.

[0080] S4, 5-20ul of the blood sample 5 is mixed with the diluent to form a 60-80ul mixed solution, and the mixed solution is dripped onto the glass cellulose membrane 1 at the through hole position of the upper cover 15. The urine sample can be directly added.

[0081] S5. The waiting reaction time is 6 to 10 minutes. The detection concentration change does not exceed 10% within 10 minutes after the chromatography is completed, and does not exceed 15% within one hour. The time stability is very good. The CV of the key detection interval of the same sample does not exceed 10%. The biochemical reaction can be completed in a very short time and a more precise result can be achieved.

[0082] The reaction is that the mixed liquid moves toward the absorbent paper 13: the small molecules to be detected in the blood sample or urine sample 5 first bind to the sprayed coupled probe and the independent antibody probe in the spray probe area 2, and then bind to the antigens on T1, T2 and C.

[0083] The reaction principle is: since the analytes involved are small molecules, the competition detection principle is used, the concentration of the analyte is inversely proportional to the fluorescence intensity of the quantum dots of the corresponding detection lines, the quantitative value is corrected by the ratio of the T line and the C line, and the sample type is corrected by the fixed parameter r of the population.

[0084] If a group of people or patients are under great stress or have mental illnesses such as anxiety and depression, they may secrete higher levels of cortisol. The corresponding T-line quantum dot fluorescence intensity is weaker, while the C-line fluorescence value is basically unaffected by the analyte, and the T / C value is smaller, which is converted to a higher cortisol concentration. At the same time, the DHEA / DHEAS hormone, the upstream precursor of cortisol in this group of people, is relatively low. In this methodology, it is manifested as a stronger fluorescence intensity of the corresponding T-line quantum dots and a higher T / C value, which is converted to a lower DHEA / DHEAS concentration. For the same individual, the ratio of cortisol concentration to DHEA / DHEAS concentration (i.e., T 皮质醇 / T DHEA / DHEAS ) can better assess the individual's stress and mental condition.

[0085] S6. Use the detection and analysis device to read the fluorescence data of the quality control line and the detection line position from the transparent observation window 16, calculate the concentration of cortisol and DHEA / DHEAS according to the ratio of the fluorescence data of the detection line to the fluorescence data of the quality control line, and evaluate the situation of stress and mental illness.

[0086] The application of this method includes but is not limited to the detection of stress, stress-induced stress, endocrine disorders, anxiety, depression and other mental illnesses related to the detection indicators selected by this technology.

[0087] In step S6, the detection and analysis device used is an existing fluorescence data acquisition device, such as a positioning base, a dark cavity and an in vitro detection and analysis device using the dark cavity with patent number ZL201510120128.6, or a light source module and an in vitro detection and analysis device using the light source module with patent number ZL201510116072.X, or a dark cavity and an in vitro detection and analysis device using the dark cavity with patent number ZL201510116173.X.

[0088] Of course, according to the reaction principle in step S5, in the absence of professional detection equipment, the brightness of the fluorescence can be evaluated by observation. For example, by using a UV light source or common daily necessities such as a banknote detector pen to illuminate the fluorescence values ​​on the T line and the C line, the mental state of the person to be detected can be evaluated by judging the brightness of the fluorescence values.

[0089] The quantum dots used in the present invention can be excited by the same UV light source, and the luminescent color is all red. After the reaction is completed, the concentrations of cortisol and DHEA / DHEAS and the relative concentration ratio between them can be determined by the signal ratio of the detection line and the quality control line and the signal ratio between the quality control lines (T1 / C, T2 / C, T1 / T2). A large number of domestic and foreign studies have shown that these values ​​and ratios are of reference significance for the auxiliary diagnosis of mental illnesses caused by stress and stress.

[0090] The detection principle is a small molecule competition method for single or multiple tests. When there is no substance to be tested, the T line has the highest signal value. By adjusting the spray antigen level at the T line, the probe spray ratio, and the independent C line fluorescence signal value, each T line is in a fixed ratio with the C line signal value when the concentration of the substance to be tested is at the medical cutoff value (cutoff), so that the test results can be preliminarily judged by simple visual observation under relatively simple conditions, which helps to further examine the disease in detail.

[0091] like Figure 2 , is a time stability chart of cortisol probes and detection reagents labeled with quantum dots at 25°C. The first reading was done using a portable immunofluorescence analyzer 6 minutes after the blood sample was added, until 60 minutes. There are a total of 11 clinical samples, each sample is a line, and it can be seen that the fluctuations of each sample line are small, especially after 10 minutes, indicating good time stability, and more accurate detection can be performed even when accurate timing is not possible or too busy.

[0092] like Figure 3, is a semi-quantitative screening concentration ratio diagram, 22.5ug / dL is the 95% percentile upper limit of the reference chemiluminescent cortisol clinical detection judgment of this method. In this design, the fluorescence color can be semi-quantitatively judged by the brightness and width of the T line and C line (basically around 1:1) in the concentration range of 20-23ug / dL. In this test item, cortisol and DNEA / DHEAS are both small molecules, and the competition method is used for detection. Therefore, the less the fluorescence signal, the higher the concentration of the test substance, that is, the greater the stress or the possibility of mental illness such as anxiety and depression. Therefore, the narrow cortisol T line and weak signal, the wide T line of DHEA / DHEAS, and the strong signal (or through the comparison of the two detection lines) indicate that further review and confirmation are required. It is recommended to use a handheld immunofluorescence analyzer for accurate quantitative reading and automatic reporting under the condition of having a handheld portable device.

[0093] like Figure 4 , for multi-index joint inspection, two test lines are set as T1 and T2, and the relationship between the test values ​​of cortisol and DHEA (DHEAS) (in ug / dL) and T1 / T2 can be obtained. The calculation method of each concentration is r*Tx / C, r is the conversion coefficient of the sample, which is determined by different sample types, and serum is usually 1. T1 / T2=(r*T1 / C) / (r*T2 / C). The conversion results of the two concentration curves can be used in the software to calculate the ratio. Under more stringent conditions, it can be estimated by the fluorescence intensity and width of the two bands (T1 and T2). The clinical reference range of T1 / T2 refers to the research results of more foreign cases. In pregnant women with anxiety or high stress, the ratio will reach ≥0.5, while the control group is ≤0.3, which is significantly different.

[0094] Compared with the prior art, the present invention has the following technical effects:

[0095] The present invention uses quantum dots of the same wavelength, but in a later stage, the particles are polymerized to produce monodisperse and polymerized quantum dots with the same wavelength but different dispersities, which are respectively applied to probes of different detection targets.

[0096] Using quantum dots with smaller particle sizes to label substances that are farther from the detection line, and quantum dots with larger particle sizes to label substances that are closer to the detection line, can better distinguish multiple indicators during the chromatography process and improve their respective reaction precision and reaction speed.

[0097] Using independent quality control line antigen-antibody probes, the quality control line signal is not affected by the test line, and the concentration of the test substance is determined by the ratio of the T line to the C line signal. In the process of detecting test substances related to mental illness, the signal ratio of each test substance also has diagnostic reference significance.

[0098] Blood (serum, plasma, whole blood, 20ul) or urine samples can be used for testing, and single or combined testing of cortisol or DHEA / DHEAS can be performed at one time. The blood cells in the whole blood will remain on the glass cellulose membrane 1 (the chromatography speed is extremely slow and slightly tilted in the opposite direction), while the quantum dot probe and the substance to be tested will complete the chromatography quickly and will not be affected by the blood cells.

[0099] The detection of multiple indicators can be completed in as short as 6 minutes. The change of detection concentration does not exceed 10% within 10 minutes after the chromatography is completed, and does not exceed 15% within one hour, which has good time stability. The time accuracy requirement for reading the results is low, it is easy to use, simple to operate, and low in cost, which can meet the detection accuracy requirements of grassroots and community health.

[0100] At the same time, the present invention combines the characteristics of quantum dots with high luminescence intensity, long fluorescence lifetime and small particle size. Compared with conventional colloidal gold detection, it can meet the detection of low-concentration, daily rhythmic stress-related cortisol or DHEA / DHEAS hormone small molecules. Compared with the ELISA detection method, it can meet the reading results of handheld devices, and even use the UV light source of a banknote detector pen to observe and compare the brightness of the fluorescent strips, thereby achieving the purpose of screening and evaluating mental illness in different scenarios.

[0101] The above are only preferred embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. A portable pressure objective index evaluation test strip, characterized in that: Including glass cellulose membrane, nitrocellulose membrane, absorbent paper, PVC plate and closed box cover; The PVC board is arranged in the closed box cover, the glass cellulose membrane, the nitrocellulose membrane and the absorbent paper are arranged on the PVC board, and the two ends of the nitrocellulose membrane are connected to the glass cellulose membrane and the absorbent paper respectively; A probe spraying area is arranged at one end of the glass cellulose membrane close to the nitrocellulose membrane, and the probe spraying area is sprayed with a detection-specific antibody probe and an independent quality control antibody probe, wherein the detection-specific antibody probe is made by coupling quantum dots with different particle sizes but the same luminescent wavelength with specific antibodies; The nitrocellulose membrane is provided with a quality control line and two detection lines in parallel, the quality control line is far away from the glass cellulose membrane, the detection line is close to the glass cellulose membrane, the detection lines are T1 and T2, T1 and T2 are respectively sprayed with antigens corresponding to the detection-specific antibodies, the quality control line is C, T1 is located between the glass cellulose membrane and T2, T2 is located between T1 and C, the quantum dot probe with a small marking particle size corresponds to T2 at a farther position, and the quantum dot probe with a large marking particle size corresponds to T1 at a closer position; The detection line is sprayed with an antigen that binds to a detection-specific probe, and the quality control line is sprayed with an independent quality control antigen that binds to an independent quality control antibody probe; One end of the glass cellulose membrane is placed on the nitrocellulose membrane and is slightly higher than the other end, and the glass cellulose membrane is at a slight tilt angle.

2. The portable pressure objective index evaluation test strip according to claim 1, characterized in that: The quantum dots are CdSe / ZnS core-shell quantum dots with different particle sizes and different polymerization degrees.

3. The portable pressure objective index evaluation test strip according to claim 2, characterized in that: The detection specific antibodies are two specific antibodies, namely, a cortisol specific antibody and a DHEA / DHEAS specific antibody.

4. The portable pressure objective index evaluation test strip according to claim 3, characterized in that: The detection-specific antibody includes rabbit IgG monoclonal antibody or mouse IgG monoclonal antibody against target small molecules.

5. The portable pressure objective index evaluation test strip according to claim 1, characterized in that: The independent quality control antibody in the independent quality control antibody probe is a DNP-BSA antibody, and the independent quality control antigen is a DNP-BSA antigen.

6. The portable pressure objective index evaluation test strip according to claim 1, characterized in that: The closed box cover comprises an upper cover and a lower cover. The glass cellulose membrane, nitrocellulose membrane, absorbent paper and PVC board are embedded in the lower cover as a whole. The upper cover is provided with a through hole, which is located above the end of the glass cellulose membrane away from the nitrocellulose membrane.

7. The portable pressure objective index evaluation test strip according to claim 6, characterized in that: The upper cover is provided with a transparent observation window, and the transparent observation window is located above the quality control line and the detection line.

8. A portable objective pressure index evaluation method, which is a method for non-disease diagnosis purposes, characterized in that: A portable pressure objective index evaluation test strip comprising any one of claims 1 to 7; The following steps are also included: S1. Spray specific antibody probes and independent quality control antibody probes on the probe spraying area on the glass cellulose membrane close to the nitrocellulose membrane; The detection-specific antibody probe is made of quantum dots with different particle sizes but the same luminescent wavelength coupled with specific antibodies. The detection-specific antibody is a two-in-one test combination consisting of two specific antibodies, namely, a cortisol-specific antibody and a DHEA / DHEAS-specific antibody; The antibody in the independent quality control antibody probe is DNP-BSA antibody; S2, set two detection lines and one quality control line on the nitrocellulose membrane, namely T1, T2 and C, T1 is located between the nitrocellulose membrane and T2, and T2 is located between T1 and C; S3, spray the antigen corresponding to the detection specific probe on T1 and T2; spray the DNP-BSA antigen corresponding to the quality control DNP-BSA antibody probe on C; S4, mix 5-20ul of blood sample or urine sample with diluent, and drop 60-80ul of the mixed solution onto the glass cellulose membrane under the through hole position of the upper cover of the closed box lid; S5, waiting time for response is 6 to 10 minutes; S6. Use a detection and analysis device to read the fluorescence data of the quality control line and the detection line position from the transparent observation window of the upper cover of the closed box lid, calculate the concentration of cortisol and DHEA / DHEAS according to the ratio of the fluorescence data of the detection line to the fluorescence data of the quality control line, and evaluate the stress situation.